The Effects of SGLT2 Inhibitors on Lipid Metabolism - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33535652/

Sodium glucose co-transporter 2 (SGLT2) inhibitors are effective antihyperglycemic agents by inhibiting glucose reabsorption in the proximal tubule of the kidney. Besides improving glycemic control in patients with type 2...

Ovarian cancer risk in relation to blood lipid levels and hyperlipidemia: a systematic review and meta-analysis of observational epidemiologic studies - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/32483012/

1 Department of Oncology, Georgetown University School of Medicine, Washington, DC. 2 Department of Epidemiology, University of North Carolina at Chapel Hill Gillings School of Global Public Health, Chapel Hill,...

Small Dense Low-Density Lipoprotein Cholesterol: A Residual Risk for Rapid Progression of Non-Culprit Coronary Lesion in Patients with Acute Coronary Syndrome

Source : https://www.jstage.jst.go.jp/article/jat/advpub/0/advpub_60152/_pdf

Empagliflozin increases plasma levels of campesterol, a marker of cholesterol absorption, in patients with type 2 diabetes: Association with a slight increase in high-density lipoprotein cholesterol - PubMed

Source : https://pubmed.ncbi.nlm.nih.gov/33556413/

1 Department of Endocrinology and Metabolism, Dokkyo Medical University, Japan. Electronic address: [email protected]. 2 Department of Endocrinology and Metabolism, Dokkyo Medical University, Japan. 3 Department of Infection Control and Clinical...

Lipid Level, Lipid Variability, and Risk of Multiple Myeloma: A Nationwide Population-Based Study of 3,527,776 Subjects

Source : https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7866996/

Aldo M. Roccaro, Academic Editor There is preclinical evidence that abnormalities in lipid metabolism promote cancer development, and a few studies show the association between lipid levels and multiple myeloma...